Athira Pharma, Inc. (ATHA)
NASDAQ: ATHA · Real-Time Price · USD
3.930
+0.070 (1.81%)
At close: Oct 8, 2025, 4:00 PM EDT
3.940
+0.010 (0.25%)
After-hours: Oct 8, 2025, 4:10 PM EDT
Athira Pharma Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Athira Pharma.
Price Target: $ (0.00%)
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Athira Pharma.
Recommendation Trends
| Rating | Apr '24 | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 0 | 0 | 0 | 1 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 1 | 1 | 1 | 2 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Buy → Hold Downgrades $50 → $5 | Buy → Hold | Downgrades | $50 → $5 | +27.23% | Sep 19, 2024 |
| JMP Securities | JMP Securities | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Sep 4, 2024 |
| BTIG | BTIG | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 4, 2024 |
| Rodman & Renshaw | Rodman & Renshaw | Strong Buy Initiates $220 | Strong Buy | Initiates | $220 | +5,497.96% | Aug 19, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $190 | Buy | Reiterates | $190 | +4,734.61% | Jun 20, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-6.62
from -25.19
EPS Next Year
-4.94
from -6.62
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | |||
| Avg | n/a | n/a | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -6.81 | -4.73 | |
| Avg | -6.62 | -4.94 | |
| Low | -6.36 | -5.08 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.